Celergen USA, Inc., today announced that Celergen Swiss cell therapy is ushering in a new era in human cell rejuvenation. Researched and developed by Swiss, French, and German scientists, Celergen cell treatment represents a departure from more conventional treatments of the aging process, such as invasive surgery, cosmetic enhancements, and drugs, many of which are associated with harmful side effects.